APC consultations
HNY APC and its subgroups hold open consultations on decisions which affect patient care. This may include updated formulary chapters, new or updated clinical guidelines or commissioning statements, or changes to formulary status. All comments received are carefully considered by the group which made the decision, before a final recommendation is made. Decisions are then reviewed by the HNY APC for information or approval, as appropriate.
Consultations typically run for four weeks, and comments are invited from all stakeholders across Humber and North Yorkshire. You can comment on current proposals via the links in the table below.
| Title: | Information: | Feedback: | End Date: |
| HNY Medicines, Formulary and Guidelines group proposed actions from December 2024 | On behalf of the HNY Medicines, Formulary and Guidelines group we now seek comments on the actions proposed at the December 2024 meeting. This consultation will run for five weeks and closes at 5pm on Monday 27th January 2025. | Feedback form | 5pm on Monday 27th January 2025 |
| Draft shared care protocol: hydroxychloroquine | On behalf of the HNY Medicines, Formulary and Guidelines group we now seek comments on a draft shared care protocol for hydroxychloroquine. This consultation will run for five weeks and closes at 5pm on Monday 27th January 2025. | Feedback form | 5pm on Monday 27th January 2025 |
| Draft lipid management pathway | On behalf of the HNY Medicines, Formulary and Guidelines group we now seek comments on a draft lipid management pathway. This consultation will run for five weeks and closes at 5pm on Monday 27th January 2025. | Feedback form | 5pm on Monday 27th January 2025 |
Shared care protocol: methotrexate | We now seek comments on a draft shared care protocol for methotrexate. This consultation will run for four weeks and closes at 5pm on Friday 21st February 2025. | Feedback form | 5pm on Friday 21st February 2025. |
Shared care protocols: azathioprine, leflunomide, mycophenolate, sulfasalazine | We now seek comments on 4 draft shared care protocols: ▪️Azathioprine ▪️Leflunomide ▪️Mycophenolate ▪️Sulfasalazine Comments are welcomed on all four documents; stakeholders may complete one form or multiple forms, as required. Please note this attachment is a zipped folder containing 4 word documents. This consultation will run for four weeks and closes at 5pm on Friday 21st February 2025. | Feedback form | 5pm on Friday 21st February 2025. |
Shared care protocols: amiodarone and dronedarone | We now seek comments on 2 draft shared care protocols: ▪️Amiodarone ▪️Dronedarone Comments are welcomed on both documents; stakeholders may complete one form or multiple forms, as required. Please note this attachment is a zipped folder containing 2 word documents. This consultation will run for four weeks and closes at 5pm on Friday 21st February 2025. | Feedback form | 5pm on Friday 21st February 2025. |
Shared care protocol: riluzole | We now seek comments on a draft shared care protocol for riluzole. This consultation will run for four weeks and closes at 5pm on Friday 21st February 2025. | Feedback form | 5pm on Friday 21st February 2025. |
| HNY Medicines, Formulary Group proposed actions from January 2025 | On behalf of the HNY Medicines Formulary Group, we now seek comments on the actions proposed at the January 2025 meeting. This consultation will run for five weeks and closes at 5pm on Tuesday 25th February. | Feedback form | 5pm on Tuesday 25th February 2025. |
Please direct any questions to the secretariat at nuth.nyrdtc.rxsupp@nhs.net.